Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sucampo Pharmaceuticals SCMP

Healthcare Drug Manufacturers - Specialty & Generic
"Sucampo Pharmaceuticals Inc is a part of the healthcare sector in the United States. As a global pharmaceutical company, it commercializes drugs for the treatment of various gastrointestinal, ophthalmic and oncology-based inflammatory disorders. It currently generates revenue mainly from product royalties, product sales, upfront and milestone payments, and reimbursements for development... see more

Recent & Breaking News (NDAQ:SCMP)

20% returns on trades for Bed Bath and Beyond, FireEye, General Mills, Sucampo Pharmaceuticals and Wynn Resorts

PR Newswire December 21, 2016

Sucampo Announces Pricing of $260.0 Million 3.25% Convertible Senior Notes due 2021

GlobeNewswire December 21, 2016

Mid-Afternoon Market Update: Worthington Drops On Earnings Miss; Fred's Shares Spike Higher

Benzinga.com  December 20, 2016

12 Biggest Mid-Day Losers For Tuesday

Benzinga.com  December 20, 2016

Mid-Morning Market Update: Markets Open Higher; BlackBerry Earnings Beat Views

Benzinga.com  December 20, 2016

Mid-Afternoon Market Update: Dow Climbs 250 Points; Impax Labs Shares Down Following Q3 Results

Benzinga.com  November 9, 2016

Mid-Day Market Update: Dow Surges Over 100 Points; Coty Shares Slide

Benzinga.com  November 9, 2016

Top Performing Industries For November 9, 2016

Benzinga.com  November 9, 2016

Mid-Morning Market Update: Markets Rise; Donald Trump Wins 2016 Presidential Election

Benzinga.com  November 9, 2016

Sucampo Reports Third Quarter 2016 Financial Results

GlobeNewswire November 9, 2016

Sucampo Announces Third Quarter 2016 Earnings Call

GlobeNewswire October 28, 2016

Sucampo Reports Second Quarter 2016 Financial Results

GlobeNewswire August 3, 2016

Paul Edick Joins Sucampo’s Board of Directors

GlobeNewswire July 29, 2016

Sucampo Announces Second Quarter 2016 Earnings Call

GlobeNewswire July 20, 2016

Sucampo Provides Update on Cobiprostone Development Program

GlobeNewswire July 11, 2016

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at Cantor Fitzgerald’s 2nd Annual Healthcare Conference

GlobeNewswire July 8, 2016

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Jefferies 2016 Healthcare Conference

GlobeNewswire May 31, 2016

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2016 UBS Global Healthcare Conference

GlobeNewswire May 17, 2016

Sucampo Reports Strong Results for First Quarter of 2016

GlobeNewswire May 4, 2016

Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Bank of America Merrill Lynch 2016 Healthcare Conference

GlobeNewswire May 3, 2016